Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 AlteredExpression disease BEFREE These findings indicate that a dysregulation of DNA methylation in the promoter of H19 during calcific aortic valve disease is associated with a higher expression of this lncRNA, which promotes an osteogenic program by interfering with the expression of NOTCH1. 27789555 2016
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 GeneticVariation disease BEFREE Furthermore, NOTCH1 regulates vascular and valvular endothelium, and human mutations in NOTCH1 can cause calcific aortic valve disease. 25871831 2015
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 Biomarker disease BEFREE Finally, Notch1 and NOS3 (endothelial NO synthase) display an in vivo genetic interaction critical for proper valve morphogenesis and the development of aortic valve disease. 23583836 2013
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 Biomarker disease BEFREE Notch1 receptor haploinsufficiency has also been involved in aortic valve disease in humans. 18410944 2008
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 GeneticVariation disease BEFREE This finding was supported by the discovery of a NOTCH1 frameshift mutation in an unrelated family with similar aortic valve disease, suggesting that NOTCH1 haploinsufficiency was a genetic cause of aortic valve malformations and calcification. 16601454 2006
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 GermlineCausalMutation disease ORPHANET These results suggest that NOTCH1 mutations cause an early developmental defect in the aortic valve and a later de-repression of calcium deposition that causes progressive aortic valve disease. 16025100 2005
Entrez Id: 4851
Gene Symbol: NOTCH1
NOTCH1
0.360 GeneticVariation disease BEFREE These results suggest that NOTCH1 mutations cause an early developmental defect in the aortic valve and a later de-repression of calcium deposition that causes progressive aortic valve disease. 16025100 2005
Entrez Id: 140628
Gene Symbol: GATA5
GATA5
0.300 GermlineCausalMutation disease ORPHANET GATA5 loss-of-function mutations associated with congenital bicuspid aortic valve. 24638895 2014
Entrez Id: 1482
Gene Symbol: NKX2-5
NKX2-5
0.300 GermlineCausalMutation disease ORPHANET A novel NKX2.5 loss-of-function mutation associated with congenital bicuspid aortic valve. 25438918 2014
Entrez Id: 4091
Gene Symbol: SMAD6
SMAD6
0.300 GermlineCausalMutation disease ORPHANET Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation. 22275001 2012
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.210 Biomarker disease BEFREE Finally, Notch1 and NOS3 (endothelial NO synthase) display an in vivo genetic interaction critical for proper valve morphogenesis and the development of aortic valve disease. 23583836 2013
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.210 Biomarker disease MGD
Entrez Id: 5167
Gene Symbol: ENPP1
ENPP1
0.200 Biomarker disease RGD Inhibition of ectonucleotidase with ARL67156 prevents the development of calcific aortic valve disease in warfarin-treated rats. 22659116 2012
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.200 Biomarker disease MGD
Entrez Id: 3516
Gene Symbol: RBPJ
RBPJ
0.200 Biomarker disease MGD
Entrez Id: 23493
Gene Symbol: HEY2
HEY2
0.200 Biomarker disease MGD
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 Biomarker disease BEFREE More recently, Lipoprotein(a) [Lp(a)] has been implicated as a key player in the pathogenesis of calcific aortic valve disease. 31150732 2019
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 Biomarker disease BEFREE This review summarizes recent findings of the roles played by ATX, LPA and LPA receptors (LPARs) in atherosclerosis and calcific aortic valve disease. 30928673 2019
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 GeneticVariation disease BEFREE Lipoprotein (a) [Lp(a)] has recently emerged as a causal, independent and genetic risk factor for cardiovascular disease and calcific aortic valve disease. 30986377 2019
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 GeneticVariation disease BEFREE Evidence continues to mount for an important role for elevated plasma concentrations of lipoprotein(a) [Lp(a)] in mediating risk of atherothrombotic and calcific aortic valve diseases. 29528858 2018
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 GeneticVariation disease BEFREE Lipoprotein(a) [Lp(a)] is an enigmatic lipoprotein which has been identified as a causal risk factor for coronary heart disease and calcific aortic valve disease. 29990619 2018
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 Biomarker disease BEFREE Evaluation of Lipoprotein(a) Electrophoretic and Immunoassay Methods in Discriminating Risk of Calcific Aortic Valve Disease and Incident Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis. 28904058 2017
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.070 Biomarker disease BEFREE Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis. 26685327 2016
Entrez Id: 4907
Gene Symbol: NT5E
NT5E
0.020 Biomarker disease BEFREE CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease. 31402927 2019
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.020 Biomarker disease BEFREE It is concluded that senescence-related fibrotic aortic valve disease in SAMP1 mice is associated with a decrease in serum klotho leading to inflammation, including macrophage infiltration and transforming growth factorβ-1/scleraxis-driven myofibroblast differentiation in aortic valves. 29581213 2018